Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.190
+0.020 (1.71%)
At close: Jul 17, 2026, 4:00 PM EDT
1.150
-0.040 (-3.36%)
After-hours: Jul 17, 2026, 5:45 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $18.93 million as of July 17, 2026. Its market cap has increased by 25.56% in one year.
Market Cap
18.93M
Enterprise Value
20.62M
1-Year Change
25.56%
Ranking
Category
Stock Price
$1.19
ChartMarket Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $18.93M, a decrease of -76.15%. That is a compound annual growth rate of -26.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 18.93M | 10.94% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 20.58M |
| Cellectar Biosciences | 20.30M |
| Longeveron | 20.24M |
| KALA BIO | 20.17M |
| Neuphoria Therapeutics | 19.40M |
| Lipocine | 19.17M |
| SeaStar Medical Holding | 18.94M |
| CEL-SCI | 18.88M |